Bio-Rad executives were disinterested in conducting robust training in the Federal Corrupt Practices Act and shut down his efforts to report suspected violations, Sanford Wadler testified Wednesday in his whistleblower retaliation trial.
- Goodwin Liu: In Praise of Judicial Federalism
- Squire Patton Boggs Snags Silicon Valley IP Boutique
- Uber Pays $20M to Settle Claims it Took Drivers for a Ride
- What to Expect in California Data Security and Privacy in 2017
- As Trump Takes Office, Invoking a Fighting Spirit
- Supreme Court Will Tackle Key Jurisdiction Issue That Bothers Business
A Q&A with James Burling, litigation director at the Pacific Legal Foundation, on what the change of administration means for the libertarian-leaning organization.
Goodwin Procter partner Elaine Herrmann Blais discusses the biologics case that's expected to reach the Supreme Court and why a repeal of the Affordable Care Act could have unwelcome ripple effects.
An employer's decision not to pursue a candidate is almost always final, but there are scenarios where a candidacy can be brought back to life.
When not handled properly, the selection and use of consultants and experts can create unnecessary risks for attorneys and clients.